Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."

February 9, 2018

Emmaus Medical, Inc. Selects AmerisourceBergen to Support the Launch of Endari (L-glutamine oral powder)

AmerisourceBergen, a global healthcare solutions leader, today announced that US Bioservices, an independent specialty pharmacy, has been selected by Emmaus Medical, Inc. as the specialty pharmacy for Endari (L-glutamine oral powder), for the treatment of patients with sickle cell disease.